Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.

ClinicalTrials.gov enrollment closed later-stage tilt small index

Peyronie's Disease: later-stage trial registry

A small indexed set (6 trials) with no open enrollment listed right now.

Corpus placement: #2,866 of 28,707 conditions by registered trial count.

Jump to phase mix → How counts are built

6 US clinical trials · none currently recruiting · #2,866 of 28,707 conditions by registered trial count

Peyronie's Disease: 6 US clinical trials tracked, none currently recruiting.

Peyronie's Disease is the subject of 6 registered US clinical trials on ClinicalTrials.gov, none currently recruiting. 4 are in Phase 3-4 (later-stage) and 2 in Phase 1-2 (earlier-stage). The most active sponsor is Endo Pharmaceuticals, running 2 of these trials.

Enrollment posture brief

Registry condition peyronies-disease

OPEN 0 | RECR 0% | LATE 4 | EARLY 2 | RANK #2866 | SPON 2

Volume-matched condition peers

Nearest open-share peer: Accelerated Phase Chronic Myelogenous Leukemia (0% recruiting · 12 trials)

Acute Hypoxemic Respiratory 66.7%Abdominal Aortic Aneurysms50%Acupuncture50%Acute Lymphoblastic Leukemia50%Peyronie's Disease (this)0%
Open-enrollment share among volume-matched conditions near Peyronie's Disease

Peyronie's Disease has no open enrollment in this registry pull (6 archived studies). Peers show how other volume-matched labels compare on open share. How peer matching works →

Key findings

What ClinicalTrials.gov does not surface for Peyronie's Disease on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.

  1. Peyronie's Disease is recruiting below its size-band peers.

    0 of 6 indexed trials (0%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.

  2. One sponsor concentrates Peyronie's Disease research.

    Endo Pharmaceuticals accounts for 2 of 6 trials (33.3%). 4 distinct sponsors appear on at least one study for this condition label.

  3. Most Peyronie's Disease trials plan to enrol fewer than 100 people.

    Median target enrolment is 40 among the 6 trials that report a genuine target (sentinel values excluded). 4 of those (66.7%) plan for fewer than 100 participants.

  4. Peyronie's Disease research is mostly interventional.

    6 interventional and 0 observational studies make up this index (100% interventional). Study type is sponsor-reported on ClinicalTrials.gov.

Phase 11Phase 21Phase 32Phase 42

Phase Distribution

PhaseTrial count
Phase 1 1
Phase 2 1
Phase 3 2
Phase 4 2

Top Sponsors

Endo Pharmaceuticals 2 trials
Charitable Union for the Research and Education of Peyronie's Disease 2 trials
Hybrid Medical 1 trials
Mohit Khera 1 trials

Named interventions

Most-linked intervention names on Peyronie's Disease records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.

AA4500 Biological
2 trials
Placebo Biological
2 trials
H-100 Drug
1 trials
100 units Botulinum Toxin A Drug
1 trials
Preservative free normal saline Other
1 trials
100 units of Botulinum Toxin Type A Drug
1 trials
RestoreX Penile Traction Device Device
1 trials
Incision and Grafting (I&G) Surgery Procedure
1 trials

US sites by state

Facility locations filed on Peyronie's Disease trials. A trial with sites in several states counts in each.

Utah 2 trials
New York 2 trials
New Jersey 2 trials
Minnesota 2 trials
Maryland 2 trials
Indiana 2 trials
Florida 2 trials
Connecticut 2 trials

Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.

Related

Read our methodology - how this data is sourced, computed, and verified.

What to do with this Peyronie's Disease page

6 registered trials, 0 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.

  • No Peyronie's Disease trials are currently recruiting in this registry; that can change as new trials post, or check the broader research index. Browse research indexes
  • Endo Pharmaceuticals sponsors the most Peyronie's Disease trials on record, review their full trial history before evaluating a specific study. See Endo Pharmaceuticals's trials
  • Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Peyronie's Disease condition card totals 6 registered trials; most-linked intervention AA4500; top US site state Utah. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.